Survey of the Health and Medical Research Sector to explore the impact of COVID-19 restrictions on research in Australia

30 April 2020 Research Australia is working to compile a comprehensive report for Australian governments to fully understand the impact COVID-19 is having on the sector. This brief survey is designed to gain insight into the impact of…

Read More

EndGame MedTech – offering services for new technology success in the medical device market

30 April 2020 Are you commercialising a new technology for launch into the medical device market in the US? EndGame MedTech specialise in the unique challenges of commercializing new technology in the medical device market. Their team, including…

Read More

New genes linked to severe childhood speech disorder

30 April 2020 An international study led by Melbourne researchers has discovered nine new genes linked to the most severe type of childhood speech disorder, apraxia. The research analysed the genetic make-up of 34 affected children and young…

Read More

Helping health professionals communicate in the era of COVID-19

27 April 2020 The University of Melbourne‘s “Communicating COVID-19″  course is designed for a wide range of healthcare providers both in hospital and community settings and will help provide expert-informed answers to questions Australian  health care practitioners face surrounding…

Read More

Free access to Clarivate’s BioWorld coronavirus articles

30 April 2020 Clarivate have provided free access to COVID-19 content in their BioWorld suite of news services. Viewers can access general news as well as three critical tables summarising: Vaccines and therapeutics in development Diagnostics on the…

Read More

Almac: Supporting your Clinical Trials through COVID-19 and beyond

30 April 2020 Almac Clinical Services has commenced work on numerous crucial research projects into COVID-19 treatment options for a variety of global pharmaceutical, biotech and research institutions, providing a range of solutions such as Direct to Patient, Temperature Management, Almac Adapt…

Read More

Toyota supports Melbourne hospitals with locally designed face shields

26 April 2020 Toyota has utilised its advanced design, technology and production expertise to help assist the medical community in protecting them from the COVID-19 virus by developing and manufacturing desperately needed face shields. The face shields were…

Read More

Personalised nutrition smart patch to be developed in Australia

27 April 2020 A wearable smart patch will deliver precision data to help people personalise their diets and reduce their risk of developing lifestyle-related chronic diseases like Type 2 diabetes. The world-first personalised nutrition wearable being developed by…

Read More

Offspring may inherit legacy of their father’s Toxoplasma infection

29 April 2020 Melbourne researchers at the Walter and Eliza Hall Institute have revealed for the first time that males infected with the Toxoplasma parasite can impact their offspring’s brain health and behaviour. Studying mice infected with the common parasite Toxoplasma,…

Read More

Cracking the COVID-19 immunity code

29 April 2020 Monash University’s Dr James McMahon, an infectious disease expert and hospital clinician at The Alfred and Monash Health, is leading the development of a biobank aimed at cracking the immunity code of COVID-19. The biobank enables…

Read More

UQ COVID-19 vaccine shown to induce potent protective response in pre-clinical trials

29 April 2020 The University of Queensland’s COVID-19 vaccine has passed another important milestone, showing the ability to raise high levels of antibodies that can neutralise the virus in early pre-clinical testing. UQ was tasked by the Coalition for Epidemic…

Read More

83% Survival in COVID-19 ARDS Patients with Remestemcel-L

24 April 2020 Mesoblast Limited (ASX:MSB; Nasdaq: MESO) today announced 83% survival in ventilator-dependent COVID-19 patients (10/12) with moderate/severe acute respiratory distress syndrome (ARDS) treated during the period March-April 2020 with two intravenous infusions of Mesoblast’s allogeneic mesenchymal…

Read More


News & opinion

Member Directory